Thermo Fisher Revenues Jump 7 Percent in Q2

The company's Analytical Technologies segment grew 10 percent year-over-year, helped by "especially strong growth" in its mass spectrometry business, clinical diagnostics, and biosciences business, a company official said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories